This review compiles several differentially expressed lncRNAs in IDH-mutant and IDH-wildtype gliomas, and it has been shown that lncRNAs SBF2-AS1, PVT1, MALAT1, and H19 significantly contribute to the induction of TMZ resistance. The gene discussed is IDH2; the disease is central nervous system cancer.